Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (5), 889-897
- https://doi.org/10.1038/s41436-020-0752-2
Abstract
No abstract availableFunding Information
- Stichting Neurofibromatose (NA)
This publication has 41 references indexed in Scilit:
- Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1splice-site mutations?Published by Springer Science and Business Media LLC ,2012
- Lovastatin regulates brain spontaneous low-frequency brain activity in Neurofibromatosis type 1Neuroscience Letters, 2012
- Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1Human Molecular Genetics, 2009
- Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 casesBritish Journal of Dermatology, 2009
- Impact of Neurofibromatosis Type 1 on School PerformanceJournal of Child Neurology, 2008
- Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1JAMA, 2008
- An Absence of Cutaneous Neurofibromas Associated with a 3-bp Inframe Deletion in Exon 17 of the NF1 Gene (c.2970-2972 delAAT): Evidence of a Clinically Significant NF1 Genotype-Phenotype CorrelationAmerican Journal of Human Genetics, 2007
- Intelligence in individuals with a neurofibromatosis type 1 microdeletionAmerican Journal of Medical Genetics Part A, 2004
- Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1)Genetic Epidemiology, 2002
- Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence.Journal of Neurology, Neurosurgery & Psychiatry, 1995